Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis
Yingli Qu,
No information about this author
Jianqing Ding,
No information about this author
Pan W
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: March 25, 2025
This
study
explores
the
application
of
Azathioprine
in
treatment
ulcerative
colitis
(UC)
and
challenges
associated
with
its
long-term
use.
While
short-term
studies
demonstrate
efficacy
steroid-dependent
UC,
data
on
risks,
including
malignancies,
infections,
chronic
toxicity,
remain
insufficient.
Furthermore,
impact
patients’
quality
life
over
extended
periods
is
still
unclear.
The
research
highlights
importance
optimizing
dosing
based
genomic
data,
particularly
through
TPMT
NUDT15
genotyping,
to
minimize
adverse
effects.
However,
further
needed
develop
individualized
strategies
that
can
improve
reduce
toxicity.
identification
predictive
biomarkers,
genomics
proteomics,
likely
play
a
crucial
role
improving
precision
by
identifying
patients
who
are
most
benefit
from
therapy.
Additionally,
combining
biologic
therapies
(such
as
anti-TNF
agents
or
integrin
inhibitors)
interventions
targeting
gut
microbiome
may
enhance
drug’s
effectiveness
while
reducing
reliance
steroids.
Overall,
large-scale
clinical
trials
urgently
evaluate
benefits
risks
these
emerging
therapies,
ultimately
supporting
more
personalized
approaches
for
UC
patients.
Language: Английский
Functional Genomics Using High‐Throughput Methods for Salivary Analysis in Sjögren's Disease
Oral Diseases,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
ABSTRACT
Objectives
Primary
Sjögren's
disease
(SjD)
is
a
slow‐progressing
autoimmune
that
affects
salivary
and
lacrimal
glands,
causing
dry
eyes
(xerophthalmia)
mouth
(xerostomia).
Diagnosing
SjD
involves
clinical,
serological,
histological
assessments,
but
reliable
biomarkers
are
lacking.
Methods
This
study
analyzed
the
metabolic
proteomic
profiles
of
19
female
patients
(based
on
ACR‐EULAR
criteria)
compared
to
20
healthy
individuals.
Saliva
blood
samples
were
using
mass
spectrometry
chromatography.
Proteomic
analysis
was
performed
with
nanoElute
nanoflow
system
coupled
timsTof‐Pro
spectrometer,
profiling
GC‐TOF/MS
Pegasus
HT.
Results
Statistical
tests
identified
significant
differences
in
metabolites
proteins
between
controls.
Metabolome
revealed
changes
amino
acid
synthesis,
purine
lipid
metabolism,
exposure
external
compounds.
indicated
immune‐related
inflammatory
metabolism.
GNAI2,
B2MG,
NGAL,
SLUR2,
HS90,
SODC,
A2GL
emerged
as
potential
for
SjD.
Conclusion
demonstrates
high‐performance
techniques
identifying
diagnosis
prognosis.
Data
available
via
ProteomeXchange
(PXD055629).
Language: Английский